Start an analysis for COLL
Collegium Pharmaceutical, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $150m | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Remaining authorization | $100m | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Program expiry | 31-Dec-26 | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Repurchased last quarter | $0 | 31-Aug-26 | 10-Q filed 05-Nov-26 |
| Has used an ASR | Yes | 13-Aug-26 | 10-Q filed 05-Nov-26 |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $150m | $100m | 31-Dec-26 | In July 2025, our Board of Directors authorized a new share repurchase program for the repurchase of up to $150.0 million of shares of our common stock through December 31, 2026 (the “2025-2026 Repurchase Program”).10-Q filed 05-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
Amount unknown: not in the filings we hold yet, or not stated. Hover for which.
| Month ended | Shares | Withheld & other | ASR shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|---|
| 31-Aug-26 | 0 | 3,690 | 1,556,420 | $25.70 | $0 | 10-Q filed 05-Nov-26 |
| 30-Jun-26 | 2,728 | 2,728 | — | $34.80 | $94.9k | 10-Q filed 06-Aug-26 |
| 31-May-26 | 4,502 | 4,502 | — | $35.81 | $161.2k | 10-Q filed 06-Aug-26 |
| 30-Apr-26 | 10,951 | 10,951 | — | $35.47 | $388.4k | 10-Q filed 06-Aug-26 |
Outstanding ASR
Track this ASR- Size
- $50m
- Bank
- Not found in filings
- Started
- 13-Aug-26
- Upfront shares
- 1.6m
- Final settlement
- Not found in filings
From 10-Q filed 05-Nov-26. Tracking needs your confirmation's exact dates and discount, which filings don't disclose.
Accelerated share repurchases
- $50m · Outstanding10-Q filed 05-Nov-26
- $25m · Completed10-Q filed 05-Nov-26
| Announced | Status | Size | Banks | Initial shares | Final shares | Avg price | Source |
|---|---|---|---|---|---|---|---|
| 13-Aug-26 | Outstanding | $50m | — | 1,556,420 | — | — | 10-Q filed 05-Nov-26 |
| 09-May-25 | Completed July 2025 | $25m | — | 692,281 | 129,847 | — | 10-Q filed 05-Nov-26 10-Q filed 05-Nov-26 |